Schrodinger Inc (SDGR)

Jan 13, 2025, 7:00 AM EST - 4 days ago

Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities

Dec 17, 2024, 8:30 AM EST - 4 weeks ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Nov 18, 2024, 8:30 AM EST - 2 months ago

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative

Nov 12, 2024, 10:51 AM EST - 2 months ago

Schrödinger (SDGR) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 6:50 AM EST - 2 months ago

Schrödinger Reports Third Quarter 2024 Financial Results

Nov 4, 2024, 8:30 AM EST - 2 months ago

Schrödinger to Present at Jefferies London Healthcare Conference

Oct 31, 2024, 8:30 AM EDT - 2 months ago

Schrödinger to Announce Third Quarter 2024 Financial Results on November 12

Oct 23, 2024, 6:01 AM EDT - 3 months ago

Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium

Oct 9, 2024, 6:06 AM EDT - 3 months ago

Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium

Sep 19, 2024, 2:18 PM EDT - 4 months ago

Kuehn Law Encourages Investors of Schrodinger, Inc. to Contact Law Firm

Aug 1, 2024, 12:46 AM EDT - 6 months ago

Schrödinger, Inc. (SDGR) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:05 PM EDT - 6 months ago

Schrödinger Reports Strong Second Quarter 2024 Financial Results

Jul 17, 2024, 8:58 AM EDT - 6 months ago

Schrödinger to Announce Second Quarter 2024 Financial Results on July 31

Jun 4, 2024, 11:20 AM EDT - 8 months ago

Schrodinger: Buy The Drug-Discovery Platform And Get The Pipeline Nearly For Free

May 22, 2024, 8:30 AM EDT - 8 months ago

Schrödinger to Present at Jefferies Global Healthcare Conference

May 1, 2024, 8:28 PM EDT - 9 months ago

Schrödinger, Inc. (SDGR) Q1 2024 Earnings Call Transcript

May 1, 2024, 4:00 PM EDT - 9 months ago

Schrödinger Reports First Quarter 2024 Financial Results

Apr 10, 2024, 8:30 AM EDT - 10 months ago

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

Feb 28, 2024, 8:15 PM EST - 11 months ago

Schrödinger, Inc. (SDGR) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 4:05 PM EST - 11 months ago

Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results

Feb 14, 2024, 8:30 AM EST - 1 year ago

Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28

Nov 6, 2023, 12:36 PM EST - 1 year ago

Schrodinger: Attractive Risk-Reward

Nov 1, 2023, 10:36 PM EDT - 1 year ago

Schrödinger, Inc. (SDGR) Q3 2023 Earnings Call Transcript

Nov 1, 2023, 4:00 PM EDT - 1 year ago

Schrödinger Reports Third Quarter 2023 Financial Results

Oct 18, 2023, 8:30 AM EDT - 1 year ago

Schrödinger to Announce Third Quarter 2023 Financial Results on November 1

Sep 29, 2023, 3:49 AM EDT - 1 year ago

Schrodinger: Leading The AI Healthcare Revolution

Sep 21, 2023, 2:32 PM EDT - 1 year ago

The Good And Bad: Allison Transmission & Schrodinger Inc.

ALSN

Sep 2, 2023, 11:10 PM EDT - 1 year ago

Schrodinger: More Than An AI Bubble Stock

Aug 2, 2023, 8:35 PM EDT - 1 year ago

Schrödinger, Inc. (SDGR) Q2 2023 Earnings Call Transcript

Aug 2, 2023, 4:00 PM EDT - 1 year ago

Schrödinger Reports Second Quarter 2023 Financial Results

Jul 26, 2023, 5:30 AM EDT - 1 year ago

Biotech Stocks Join AI-Fueled Rally

RXRX

Jul 19, 2023, 8:30 AM EDT - 1 year ago

Schrödinger to Announce Second Quarter 2023 Financial Results on August 2

May 21, 2023, 9:10 PM EDT - 1 year ago

Schrodinger: Reiterate Buy Rating On Strong Software Revenue Growth Ahead

May 4, 2023, 8:49 PM EDT - 1 year ago

Schrödinger, Inc. (SDGR) Q1 2023 Earnings Call Transcript

May 4, 2023, 4:00 PM EDT - 1 year ago

Schrödinger Reports Strong First Quarter 2023 Financial Results

Apr 27, 2023, 7:00 AM EDT - 1 year ago

Schrödinger Publishes Inaugural Corporate Sustainability Report

Apr 20, 2023, 8:30 AM EDT - 1 year ago

Schrödinger to Announce First Quarter 2023 Financial Results on May 4

Apr 4, 2023, 2:12 PM EDT - 1 year ago

Schrodinger: An Intriguing Story

Feb 28, 2023, 10:07 PM EST - 2 years ago

Schrödinger, Inc. (SDGR) Q4 2022 Earnings Call Transcript

Feb 28, 2023, 4:00 PM EST - 2 years ago

Schrödinger Reports Strong Fourth Quarter and Full-Year 2022 Financial Results

Feb 17, 2023, 8:30 AM EST - 2 years ago

Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 14, 2023, 7:00 AM EST - 2 years ago

Schrödinger Receives $111.3 Million Distribution from Sale of Nimbus's TYK2 Inhibitor to Takeda

Feb 13, 2023, 8:30 AM EST - 2 years ago

Schrödinger to Announce Fourth Quarter and Full-Year 2022 Financial Results on February 28

Jan 31, 2023, 8:30 AM EST - 2 years ago

Schrödinger to Present at SVB Securities Global Biopharma Conference

Jan 24, 2023, 8:28 AM EST - 2 years ago

Schrodinger: Unlocking The Potential Of Computer-Assisted Drug Discovery During Tough Times

Jan 21, 2023, 11:46 PM EST - 2 years ago

Schrodinger: Solving The Critical Need For AI/ML In The Biopharma Industry

Jan 9, 2023, 7:00 AM EST - 2 years ago

Schrödinger Provides Update on Progress Across the Business and Outlines 2023 Company Strategic Priorities

Dec 19, 2022, 8:15 AM EST - 2 years ago

Schrodinger: Upgrading My Rating Post The Recent Nimbus Deal

Dec 12, 2022, 7:00 AM EST - 2 years ago

Schrödinger Presents New Preclinical Data Supporting Advancement of CDC7 Inhibitor Development Candidate, SGR-2921, at American Society of Hematology 2022 Annual Meeting

Nov 22, 2022, 1:35 AM EST - 2 years ago

Schrödinger: A Strong Player In The Field Of Drug Development Technology